Augmedix has made the Healthcare Technology Report’s Top 100 Healthcare Technology Companies of 2022.
“The awardees on this year’s list represent the absolute best in the healthcare technology space,” the Healthcare Technology Report wrote. “These companies are changing the face of the industry.”
What all the awardees have in common is that they are leveraging their talent to find innovative solutions to healthcare’s most pressing issues. In the process, they are saving lives and extending healthspans.
This year’s top 100 companies represent a range of specialties, from genomics to therapeutics, data analysis, and more. What they have in common is that they are having an impact on patients’ lives, whether through direct treatment with therapeutics, for example, or providing technologically advanced products and services to healthcare providers.
“They are driving the industry forward and creating an environment in which better care for all is possible,” said the Healthcare Technology Report.
When discussing Augmedix, the Healthcare Technology Report called the company “one of the most important names in medical data services.”
Augmedix’s services are driven by its Ambient Automation Platform, an AI-driven data services platform that “expedites the communication of medical documentation among primary providers, specialist clinics, emergency departments, and large-scale health systems.” It uses HIPAA-compliant technology, natural language processing, automated speech recognition, and machine learning in order to facilitate real-time communication of healthcare data.
From its establishment in 2012, Augmedix has grown to employ more than 1,000 people. Its client base comprises 15 major health systems who, together, represent 10 percent of the clinicians in the U.S.
“The company held an impressive IPO on the Nasdaq last year after raising more than $100 million in VC funding, likely fueled by its ongoing development partnership with Google for advanced documentation technology,” the Healthcare Technology Report wrote.
Read the full article here.